ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Estrogen receptor β attenuates renal fibrosis by suppressing the transcriptional activity of Smad3

Cao, Rong; Su, Wen; Sheng, Jingyi; Guo, Yanlin; Su, Jie; Zhang, Cong; Wang, Honglian; Tang, Yizhe; Chen, Lei; Qiao, Rongfang; Chen, Xiaocong; Huang, Xiaoru; Zhou, Yunfeng; Zhu, Lizhen; Bai, Zirui; Zhang, Xiaoyan; Gustafsson, Jan-Ake; Wan, Qijun*; Lan, Hui-yao*; Guan, Youfei*广东省人民医院; 河北医科大学; 深圳市第二人民医院; 1
Biochimica et Biophysica Acta - Molecular Basis of Disease2023-8DOI: 10.1016/j.bbadis.2023.166755
2被引5阅读
引用收藏
分享

摘要

Renal fibrosis (RF) is a common pathway leading to chronic kidney disease (CKD), which lacks effective treatment. While estrogen receptor beta (ER beta) is known to be present in the kidney, its role in RF remains unclear. The present study aimed to investigate the role and underlying mechanism of ER beta during RF progression in patients and animal models with CKD. We found that ER beta was highly expressed in the proximal tubular epithelial cells (PTECs) in healthy kidneys but its expression was largely lost in patients with immunoglobin A nephropathy (IgAN) and in mice with unilateral ureter obstruction (UUO) and subtotal nephrectomy (5/6Nx). ER beta deficiency markedly exacerbated, whereas ER beta activation by WAY200070 and DPN attenuated RF in both UUO and 5/6Nx mouse models, suggesting a protective role of ER beta in RF. In addition, ER beta activation inhibited TGF-beta 1/Smad3 signaling, while loss of renal ER beta was associated with overactivation of the TGF-beta 1/Smad3 pathway. Furthermore, deletion or pharmacological inhibition of Smad3 prevented the loss of ER beta and RF. Mechanistically, activation of ER beta competitively inhibited the association of Smad3 with the Smad-binding element, thereby downregulating the transcription of the fibrosis-related genes without altering Smad3 phosphorylation in vivo and in vitro. In conclusion, ER beta exerts a renoprotective role in CKD by blocking the Smad3 signaling pathway. Thus, ER beta may represent as a promising therapeutic agent for RF.

学科与关键词

关键词
CKDER betaTubular epithelial cellsTGF-betaSmad3
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Biochimica et Biophysica Acta - Molecular Basis of Disease
发表日期
2023-08
卷期
第 1869 卷, 第 6 期
页码
166755
DOI
10.1016/j.bbadis.2023.166755
语言
DUTCH
成果收录
SCIE
资助标注
Guangdong Basic and Applied Basic Research Foundation [2021A1515010991]; Shenzhen Science and Technology Project [JCYJ20210324103602006, JCYJ202103240 94213037]; Shenzhen Second People's Hospital Clinical Research Project [20223357004]; National Natural Science Foundation of China [81600534, 81870405, 81970606, 81970595, 82270703]; Shenzhen Key Medical Discipline Construction Fund [SZXK009]; Research Grants Council of Hong Kong [14117418, 14104019, 14101121]; Guangdong-Hong Kong-Macao-Joint Labs Program from Guangdong Science and Technology Department [2019B121205005]; National Key Research and Development Program of China [2020YFC2005000]; Lui Che Woo Institute of Innovative Medicine (CARE program)

作者

  • C

    Cao, Rong (第一作者)

    1 · 2 · shenzhen univ

  • S

    Su, Wen

    shenzhen univ

查看全部 20 位作者收起作者
  • S

    Sheng, Jingyi

    chinese univ hong kong · southeast univ

  • G

    Guo, Yanlin

    dalian med univ · inst med

  • S

    Su, Jie

    shenzhen univ

  • Z

    Zhang, Cong

    dalian med univ · inst med

  • W

    Wang, Honglian

    chinese univ hong kong

  • T

    Tang, Yizhe

    1 · shenzhen univ · second peoples hosp shenzhen

  • C

    Chen, Lei

    shenzhen univ

  • Q

    Qiao, Rongfang

    dalian med univ · inst med

  • C

    Chen, Xiaocong

    guangdong prov peoples hosp · shenzhen univ

  • H

    Huang, Xiaoru

    1 · shenzhen univ

  • Z

    Zhou, Yunfeng

    shenzhen univ

  • Z

    Zhu, Lizhen

    shenzhen univ

  • B

    Bai, Zirui

    shenzhen univ

  • Z

    Zhang, Xiaoyan

  • G

    Gustafsson, Jan-Ake

  • W

    Wan, Qijun (通讯)

    1 · 2 · shenzhen univ

  • L

    Lan, Hui-yao (通讯)

    chinese univ hong kong

  • G

    Guan, Youfei (通讯)

    dalian med univ · inst med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417